Cashu Logo
HomeWatchlistNewsSignalsPicks
DJI
-0.65%
SPX
-0.05%
IXIC
+0.13%
FTSE
-1.11%
N225
-1.77%
AXJO
-1.36%
Cashu Logo
⌘K
Log In
HomeWatchlistNewsSignals
Stocks
0.00 (0.00%)
0.000
USD
At close at --,----
Cashu Logo Alt
Cashu is the #1 way to stay ahead of the markets, know why your favourite stocks are moving and access valuation signals that smash the market.

Company

  • About Us
  • Careers
  • Blog
  • News

Help & Support

  • Help Center
  • Contact Us
  • Pro Support

Legal

  • Privacy Policy
  • Terms of Use
InstagramYouTube

© 2024 Cashu PTY LTD.

Stocks
Health Care
nby
Novabay Pharmaceuticals
NYSE MKT LLC: NBY
-0.08 (-6.82%)
1.025
USD
At close at Nov 14, 21:38 UTC
Summary
News
Signals
Benchmarks
Financials

Latest Novabay Pharmaceuticals News

businesswire.com

NovaBay Pharmaceuticals Completes the Sale of its Eyecare Business to PRN and Further Adjourns its Special Meeting of Stockholders on Dissolution Proposal

10 months ago
businesswire.com

NovaBay Pharmaceuticals Announces the Further Adjournment of the Special Meeting of Stockholders

Feature Image for interests on Consumer Cyclical, Healthcare, Stock from businesswire.com
11 months ago
businesswire.com

Prominent Independent Proxy Advisory Firm ISS Supports NovaBay Pharmaceuticals’ Proposals to Authorize the Sale of its Avenova Brand

about 1 year ago
businesswire.com

NovaBay Pharmaceuticals Accepts Revised Offer from PRN Physician Recommended Nutriceuticals, LLC and Enters into an Amendment to the Asset Purchase Agreement to Increase Purchase Price

about 1 year ago
businesswire.com

NovaBay Pharmaceuticals Signs Definitive Agreement to Sell its Avenova Assets

Feature Image for interests on Consumer Cyclical, Healthcare, Stock from businesswire.com
about 1 year ago
finance.yahoo.com

Eyenovia Announces Appointment of Experienced Finance and Accounting Executive Andrew Jones as Chief Financial Officer

Feature Image for interests on Andrew Jones, Approved Products, Chief Executive Officer, Chief Financial Officer from finance.yahoo.com
about 1 year ago
businesswire.com

NovaBay Pharmaceuticals Reports Second Quarter 2024 Financial Results

over 1 year ago
businesswire.com

NovaBay Pharmaceuticals to Hold Second Quarter 2024 Conference Call on August 13, 2024

Feature Image for interests on Consumer Cyclical, Healthcare, Stock from businesswire.com
over 1 year ago
businesswire.com

NovaBay Pharmaceuticals Reports Record Amazon Prime Day Sales

over 1 year ago
businesswire.com

NovaBay Pharmaceuticals Announces Closing of $3.87 Million Underwritten Public Offering, Including Partial Exercise of Overallotment Option

over 1 year ago
Join our newsletter to keep up to date with us!

Latest Cashu News

publisher logo
Cashu

NovaBay Pharmaceuticals Sells Avenova Business for $11.5 Million Amid Strategic Restructuring

10 months ago
publisher logo
Cashu

NovaBay Pharmaceuticals (NBY) Seeks Stockholder Approval for Avenova Sale and Liquidation Plans

11 months ago
publisher logo
Cashu

NovaBay Pharmaceuticals Proposes Avenova Sale and Liquidation to Enhance Shareholder Value

12 months ago